Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Dore

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
The International Journal on Drug Policy|July 26, 2021
Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnelL Lafferty, J Rance, G J Dore, et al.
Journal of Viral Hepatitis|September 16, 2010
Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, AustraliaJ Grebely, J Bryant, P Hull, et al.
AIDS (London, England)|January 1, 1997
HIV-1 infection among female commercial sex workers in rural ThailandJ A Gray, G J Dore, Y Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1995
Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazoleG J Dore, D J Marriott, M C Hing, et al.
The Journal of Infectious Diseases|August 7, 1999
Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating CommitteeG J Dore, D A Cooper, C Barrett, et al.
AIDS (London, England)|July 23, 1999
Changes to AIDS dementia complex in the era of highly active antiretroviral therapyG J Dore, P K Correll, Y Li, et al.
Journal of Viral Hepatitis|May 16, 2014
Lower life expectancy among people with an HCV notification: a population-based linkage studyM Alavi, M G Law, J Grebely, et al.
Epidemiology and Infection|May 19, 2006
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug usersJ Amin, M G Law, J Micallef, et al.
The International Journal on Drug Policy|May 31, 2022
"You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison settingL Lafferty, J Rance, M Byrne, et al.
AIDS Care|February 19, 2008
Experience of hepatitis C testing among injecting drug users in Sydney, AustraliaC A Day, B White, H H Thein, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
The International Journal on Drug Policy|July 26, 2021
Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnelL Lafferty, J Rance, G J Dore, et al.
Journal of Viral Hepatitis|September 16, 2010
Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, AustraliaJ Grebely, J Bryant, P Hull, et al.
AIDS (London, England)|January 1, 1997
HIV-1 infection among female commercial sex workers in rural ThailandJ A Gray, G J Dore, Y Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1995
Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazoleG J Dore, D J Marriott, M C Hing, et al.
The Journal of Infectious Diseases|August 7, 1999
Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating CommitteeG J Dore, D A Cooper, C Barrett, et al.
AIDS (London, England)|July 23, 1999
Changes to AIDS dementia complex in the era of highly active antiretroviral therapyG J Dore, P K Correll, Y Li, et al.
Journal of Viral Hepatitis|May 16, 2014
Lower life expectancy among people with an HCV notification: a population-based linkage studyM Alavi, M G Law, J Grebely, et al.
Epidemiology and Infection|May 19, 2006
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug usersJ Amin, M G Law, J Micallef, et al.
The International Journal on Drug Policy|May 31, 2022
"You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison settingL Lafferty, J Rance, M Byrne, et al.
AIDS Care|February 19, 2008
Experience of hepatitis C testing among injecting drug users in Sydney, AustraliaC A Day, B White, H H Thein, et al.
Pageof 7